Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats

被引:85
作者
Zhang, YH [1 ]
Raap, DK [1 ]
Garcia, F [1 ]
Serres, F [1 ]
Ma, Q [1 ]
Battaglia, G [1 ]
Van de Kar, LD [1 ]
机构
[1] Loyola Univ, Stritch Sch Med, Dept Pharmacol, Maywood, IL 60153 USA
关键词
serotonin; SSRI; anxiety; defecation; ACTH; oxytocin; prolactin; renin;
D O I
10.1016/S0006-8993(99)02289-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of the present study was to investigate the anxiolytic effects of long-term treatment with fluoxetine in rats. Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine, are used to treat anxiety and panic disorders, in addition to treating depression. A major concern with SSRIs is a 2-3-week delay in their therapeutic effects. SSRIs share with anxiolytic 5-HT1A agonists the ability to produce desensitization of post-synaptic 5-HT1A receptors. To investigate the anxiolytic effects of fluoxetine, rats were treated for 14 days with fluoxetine (10 mg kg(-1) day(-1), i.p.). The rats were stressed using a conditioned stress procedure and tested one day after the last fluoxetine injection. Fluoxetine decreased stress-induced defecation (by 60%), reversed the stress-induced suppression of exploring behavior (by 59%) and shortened the duration of stress-induced freezing behavior (by 11.5%). However, the stress-induced increase in plasma levels of ACTH, corticosterone, oxytocin, prolactin and renin were not inhibited by fluoxetine treatment. These findings suggest that neuroadaptive changes induced by sustained inhibition of serotonin (5-HT) reuptake, contribute to the mechanism of the anxiolytic effects of fluoxetine. in contrast, the neuroendocrine responses to conditioned stress are not affected by these neuroadaptive changes. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:58 / 66
页数:9
相关论文
共 86 条
[21]   Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses [J].
Feldman, S ;
Newman, ME ;
Gur, E ;
Weidenfeld, J .
NEUROREPORT, 1998, 9 (09) :2007-2009
[22]   PARAVENTRICULAR NUCLEUS SEROTONIN MEDIATES NEURALLY STIMULATED ADRENOCORTICAL SECRETION [J].
FELDMAN, S ;
CONFORTI, N ;
MELAMED, E .
BRAIN RESEARCH BULLETIN, 1987, 18 (02) :165-168
[23]   POSTERIOR HYPOTHALAMIC DEAFFERENTATION OR 5,7-DIHYDROXYTRYPTAMINE INHIBIT CORTICOTROPIN-RELEASING HORMONE, ACTH AND CORTICOSTERONE RESPONSES FOLLOWING PHOTIC-STIMULATION [J].
FELDMAN, S ;
WEIDENFELD, J .
NEUROSCIENCE LETTERS, 1995, 198 (02) :143-145
[24]   Sex steroid control of mood, mental state and memory [J].
Fink, G ;
Sumner, BEH ;
McQueen, JK ;
Wilson, H ;
Rosie, R .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (10) :764-775
[25]  
GAILLET S, 1991, EXP BRAIN RES, V87, P173
[26]   Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies [J].
Gardier, AM ;
Malagie, I ;
Trillat, AC ;
Jacquot, C ;
Artigas, F .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1996, 10 (01) :16-27
[27]  
GERSHON MD, 1990, NEUROPSYCHOPHARMACOL, V3, P385
[28]   Selective serotonin reuptake inhibitors in the treatment of affective disorders - III. Tolerability, safety and pharmacoeconomics [J].
Goldstein, BJ ;
Goodnick, PJ .
JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (03) :S55-S87
[29]   Dual role of 5-HT in defense and anxiety [J].
Graeff, FG ;
Viana, MB ;
Mora, PO .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (06) :791-799
[30]   The 5-HT1A receptor is not involved in emotional stress-induced rises in stress hormones [J].
Groenink, L ;
Mos, J ;
VanDerGugten, J ;
Olivier, B .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 55 (02) :303-308